Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Nxstage Medical Inc (NXTM)

Nxstage Medical Inc (NXTM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Nxstage Medical Inc 350 MERRIMACK STREET LAWRENCE MA 01843 USA

www.nxstage.com P: 978-687-4700

Description:

NxStage Medical, Inc. is a medical device company, headquartered in Lawrence, Massachusetts, USA, that develops, manufactures and markets innovative systems for the treatment of end-stage renal disease, or ESRD, and acute kidney failure.

Key Statistics

Overview:

Market Capitalization, $K 2,000,400
Shares Outstanding, K 66,685
Annual Sales, $ 393,940 K
Annual Net Income, $ -14,470 K
Last Quarter Sales, $ 108,120 K
Last Quarter Net Income, $ 810 K
60-Month Beta 0.25
% of Insider Shareholders 4.90%
% of Institutional Shareholders 80.34%

Growth:

1-Year Return 23.05%
3-Year Return 97.76%
5-Year Return 116.29%
5-Year Revenue Growth 62.70%
5-Year Earnings Growth 15.38%
5-Year Dividend Growth 0.00%

Per-Share Information:

Next Earnings Date 02/22/19
Earnings Per Share ttm -0.08
EPS Growth vs. Prev Qtr 125.00%
EPS Growth vs. Prev Year 107.14%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

NXTM Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward 136.36
Price/Earnings to Growth N/A
Return-on-Equity % -2.50%
Return-on-Assets % -1.60%
Profit Margin % -3.67%
Debt/Equity N/A
Price/Sales 4.70
Price/Cash Flow 103.07
Price/Book 8.71
Book Value/Share 3.44
Interest Coverage -19.36
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar